Mr. Stephen Davis reports

FREQUENCY EXCHANGE CLOSES 1ST TRANCHE OF PRIVATE PLACEMENT

Frequency Exchange Corp., further to its news release dated March 10, 2025, which announced a non-brokered private placement offering up to an aggregate of two million units at a price of 25 cents per unit for gross proceeds of up to $500,000, has closed the first tranche of its non-brokered private placement raising proceeds in aggregate of $103,525.

The company issued 414,102 units at a price of 25 cents per unit. Each unit comprises one common share and one common share purchase warrant, having an exercise price of 40 cents per warrant and a term of 24 months from the date of issuance. The warrants are subject to an acceleration clause, whereby if the volume-weighted average trading price of the common shares on the TSX Venture Exchange is at least 60 cents per common share for any period of 10 consecutive trading days, the company may, at its sole option, accelerate the expiry date of warrants to the date that is not less than 21 days following the date upon which notice of the accelerated expiry date is provided by the company by way of news release.

All securities issued in connection with the first tranche of the private placement are subject to a statutory hold period expiring July 15, 2025.

The company intends to use the proceeds from the private placement for general corporate, for working capital purposes, for paying down liabilities and for marketing initiatives.

The private placement is subject to TSX Venture Exchange final approval.

Based in British Columbia, Canada, Frequency Exchange is focused on the development and global commercialization of a wearable frequency delivery system. The company's specialized frequency sets are designed to enhance wellness and improve performance. The brand Nikki is the third generation of wearable technology created by the company. Now the company has one frequency delivery system it calls Nikki, which means "the victor of the people," which can be used in multiple ways, including Lyme disease. This wearable technology combined with the frequency sets is the result of years of development and experimentation with advanced bioenergetic technology.

We seek Safe Harbor.